NEW YORK, March 21 /PRNewswire/ -- The growing impact that China is having on the global pharmaceutical marketplace is currently being felt by the industry on a wide scale in areas such as outsourcing, clinical trials, manufacturing and more recently, drug discovery and development. In an effort to reduce costs and shorten time-to-market, the pharmaceutical and biotech industry is increasingly looking to China. But what should the industry realistically expect from China in the coming years?
“Impact China II: Pharmaceutical R&D Global Summit,” an event organized by the Strategic Research Institute, will separate the “hype vs. reality” surrounding the Chinese market by providing an unbiased look into the current state of the industry. Scheduled to take place on May 21-24, 2006 in Beijing, China, this groundbreaking series will lend a platform for hundreds of scientific and business leaders in the pharmaceutical industry to discuss the opportunities and challenges ahead in the rapidly developing Chinese market.
Over 75 speakers will participate in presentations, panel discussions and workshops covering:
* A Comparison of China vs. India, Japan, Asia-Pacific * Intellectual Property & Patent Protection/Enforcement * Venture Capital Investment, Technology Valuation/Transfer, East/West M&As * The Emerging Drug Discovery Landscape in China * Outsourcing Preclinical & Clinical R&D to China * Manufacturing, APIs and Generics in China * Regulatory Insights in Clinical Trials, GMPs and Drugs/Biologics * Business Practices, Commercialization and Marketing Strategies in the Chinese Market * East/West Partnerships, Licensing, and Business Development Strategies
For the full agenda, to register for the conference, or to inquire about the sponsorship & exhibition opportunities offered, please contact the event director, Jon E. Liong at jliong@srinstitute.com or call (212) 967-0095 x243. The discounted early registration rate will expire on March 31, 2006. For more information, visit the conference website at http://www.srinstitute.com/china.
Strategic Research Institute
CONTACT: Jon E. Liong of Strategic Research Institute, +1-212-967-0095x243, jliong@srinstitute.com
